Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.24.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 13,406 $ 6,071
Short-term investments 1,096 17,859
Income taxes receivable 208 38
Prepaid expenses and other current assets 1,144 1,628
Total current assets 15,854 25,596
Property and equipment, net 30 51
Restricted cash 34 34
Other assets 6 578
Total assets 15,924 26,259
Current liabilities:    
Accounts payable 835 4,996
Accrued expenses 3,492 7,761
Exchangeable notes 13,708  
Other current liabilities 668 761
Total current liabilities 18,703 13,518
Exchangeable notes   11,453
Royalty-linked notes 8,728 7,503
Other liabilities   188
Total liabilities 27,431 32,662
Commitments and contingencies (Note 14)
Shareholders' deficit    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at September 30, 2024 and December 31, 2023; no shares issued at September 30, 2024 and December 31, 2023
Ordinary shares, $0.01 par value per share: 80,000,000 shares authorized at September 30, 2024 and December 31, 2023, 22,705,994 shares issued at September 30, 2024; 13,499,003 shares issued at December 31, 2023 227 135
Additional paid-in capital 467,754 454,759
Accumulated deficit (479,490) (461,298)
Accumulated other comprehensive income 2 1
Total shareholders' deficit (11,507) (6,403)
Total liabilities and shareholders' deficit $ 15,924 $ 26,259